Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
Greifswald, Germany
Medical clinic in Greifswald, Mecklenburg-Vorpommern
Ferdinand-Sauerbruch-Straße, 17475 Greifswald
About Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
"Im Einzelnen bieten wir Ihnen in unserer Geburtshilfe und Perinatalmedizin eine individualisierte Betreuung sowohl vor, während als auch nach der Schwangerschaft. Im gynäkologischen Schwerpunkt werden die Erkrankungen des weiblichen urogenitalen Systems nach den neuesten Erkenntnissen behandelt. Besonderer Schwerpunkt liegt dabei in der Behandlung der Harninkontinenz. Unsere Gynäkologische Onkologie ermöglicht Ihnen eine hoch spezialisierte und nach aktuell wissenschaftlichen Erkenntnissen ausgerichtete Diagnostik und Behandlung bösartiger Erkrankungen. Im zertifizierten Interdisziplinären Brustzentrum werden gut- und bösartige Erkrankungen der Brust diagnostiziert und behandelt."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
AGO Study Group
3
Clinical Trials at Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
During the past decade, Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
1999-12-01
2004-10-01
Completed
900
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
2003-07-01
2004-08-01
Completed
36
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
2010-07-01
2020-12-31
Completed
408
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-03-08
2022-08-12
Completed
1,301
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are
"Ovarian Cancer" (5 trials), "Breast Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Peritoneal Neoplasms" (2 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
Most popular intervention types in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are "Drug" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
The vast majority of trials in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are
5 trials for "Female" genders and 2 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum
Currently, there are NaN active trials in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".